X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management

M Engelen, S Kemp, M De Visser, BM van Geel… - Orphanet journal of rare …, 2012 - Springer
Abstract X-linked adrenoleukodystrophy (X-ALD) is the most common peroxisomal disorder.
The disease is caused by mutations in the ABCD1 gene that encodes the peroxisomal …

Adrenoleukodystrophy–neuroendocrine pathogenesis and redefinition of natural history

S Kemp, IC Huffnagel, GE Linthorst… - Nature Reviews …, 2016 - nature.com
X-Linked adrenoleukodystrophy (ALD) is a peroxisomal metabolic disorder with a highly
complex clinical presentation. ALD is caused by mutations in the ABCD1 gene, which leads …

Skewed X-inactivation is common in the general female population

E Shvetsova, A Sofronova, R Monajemi… - European Journal of …, 2019 - nature.com
X-inactivation is a well-established dosage compensation mechanism ensuring that X-
chromosomal genes are expressed at comparable levels in males and females. Skewed X …

X-linked adrenoleukodystrophy in women: a cross-sectional cohort study

M Engelen, M Barbier, IME Dijkstra, R Schür… - Brain, 2014 - academic.oup.com
X-linked adrenoleukodystrophy is the most common peroxisomal disorder. The disease is
caused by mutations in the ABCD1 gene that encodes the peroxisomal transporter of very …

The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis

C Wiesinger, FS Eichler, J Berger - The application of clinical …, 2015 - Taylor & Francis
X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene
encoding a peroxisomal ABC transporter. In this review, we compare estimates of incidence …

Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy

YRJ Jaspers, HAF Yska, CG Bergner… - Communications …, 2024 - nature.com
Background X-linked adrenoleukodystrophy (ALD) is a neurometabolic disorder caused by
pathogenic variants in ABCD1 resulting very long-chain fatty acids (VLCFA) accumulation in …

Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study

A D'Amore, A Tessa, C Casali, MT Dotti, A Filla… - Frontiers in …, 2018 - frontiersin.org
Hereditary spastic paraplegia (HSP) refers to a group of genetically heterogeneous
neurodegenerative motor neuron disorders characterized by progressive age-dependent …

The impact of X-chromosome inactivation on phenotypic expression of X-linked neurodevelopmental disorders

BA Brand, AE Blesson, CL Smith-Hicks - Brain Sciences, 2021 - mdpi.com
Nearly 20% of genes located on the X chromosome are associated with
neurodevelopmental disorders (NDD) due to their expression and role in brain functioning …

Clinical and molecular diagnosis of Beckwith-Wiedemann syndrome with single-or multi-locus imprinting disturbance

L Fontana, S Tabano, S Maitz, P Colapietro… - International journal of …, 2021 - mdpi.com
Beckwith-Wiedemann syndrome (BWS) is a clinically and genetically heterogeneous
overgrowth disease. BWS is caused by (epi) genetic defects at the 11p15 chromosomal …

Preferential X chromosome inactivation as a mechanism to explain female preponderance in myasthenia gravis

V Nicolì, SM Tabano, P Colapietro, M Maestri… - Genes, 2022 - mdpi.com
Myasthenia gravis (MG) is a neuromuscular autoimmune disease characterized by
prevalence in young women (3: 1). Several mechanisms proposed as explanations for …